Patent · US Active

Anti-EphA2 antibodies and methods of use thereof

US10406225B2 · kind B2 · utility

0Cited by

2References

30Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Yu Zhou · Tempe, US
James D. Marks · Kensington, US

Key dates

Filing date	Aug 9, 2016
Grant date	Sep 10, 2019
Priority date	—
Expiry date	Aug 9, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Antibodies that bind to tumor associated antigen CD44 or to tumor associated antigen EphA2, are disclosed herein, as well as related compositions and methods of use. Methods of use encompass cancer therapies, diagnostics, and screening methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.